Background
and Rationale
Securing the airway is one of the primary concern of anaesthesiologist
in patient undergoing surgery in general anaesthesia. Tracheal intubation has
been for years the technique of choice for airway management during surgical
procedures under general anesthesia. However, it is not a procedure without
risk and limitation. Besides technical challenges in tube placement there are
some complication that range from events such as trauma in airway,laryngospasm,
laryngeal edema, to other minor events such as hoarseness of voice and
postoperative sore throat. There have been very limited studies comparing the
LMA Blockbuster and Baska mask. Therefore, the aim of this study is to compare
the effectiveness of the LMA blockbuster and the Baska mask in terms of ease of
insertion, quality of ventilation, oropharyngeal leak pressure and incidence of
post-operative complications. We hypothesized that the Baska mask would
withstand higher inflation pressure with the cuffless membranous bowl without
having a problem with diffusion of nitrous oxide, have faster placement time with
less laryngopharyngeal morbidity in postoperative period as compared to LMA
Blockbuster in patients undergoing elective surgeries for laparoscopic
cholecystectomy.
Importance of the research proposal: The study will be
able to provide better option for laparoscopic cholecystectomy procedures
Research
Hypothesis:
·
There
should be a significant difference in outcomes of patients undergoing
laparoscopic cholecystectomy using LMA Blockbuster and Baska mask.
OBJECTIVES
Primary
Objective:
·
To
compare oropharyngeal leak pressure (OLP) between Baska mask and LMA
Blockbuster in patients undergoing laparoscopic cholecystectomy.
Secondary
Objective:
·
Ease
of insertion
·
Haemodynamic
parameters
·
Complications
during insertion like laryngospasm, trauma and blood staining
·
Post-operative
airway morbidity (hoarseness of voice, sore throat, dysphagia)
Study
design and methods:
Study
Settings:
The
study will be conducted in Department of Anaesthesiology in collaboration of
general surgery department of King George’s Medical University, Lucknow after taking
written and informed consent from the patients.
Study
design:
Prospective,
Randomized, Comparative study.
Study
duration: One year
Sample
size: Total 86
cases included in the study
Inclusion and exclusion criteria:
Inclusion Criteria:
• Patients of either sex
• Aged 18-60 years
• ASA physical status I-II
• Undergoing elective laparoscopic
cholecystectomy of less than 2hrs
Exclusion criteria:
·
Patients
not giving written informed consent
·
Patients
having anticipated difficult airway
·
Inter
incisor distance < 2.5 cm
·
Any
associated neurological disorders, gastroesophageal reflux disease
·
Body
mass index ≥30kg/m2
·
Any
contraindication to supraglottic airway devices
·
Inadequate
fasting, full stomach, pregnancy, reactive airway disease etc.
Sample size:
Sample
size is calculated on the basis of proportion of ease of insertion in Baska
Mask and LMA Blockbuster groups using the formula

Where
p1 = 0.58 (58%) proportion of ease of insertion in Baska Mask group p2 = 0.76
(76%) proportion of ease of insertion in LMA Blockbuster group e = 0.25(p1/p2),
the risk ratio considered to be clinically significant Type I error, α=5% Type
II error β=10% for detecting results with power of study 90%
The
sample size is n = 43 each group
(Chaudhary UK, Mahajan SR,
Mahajan M, Sharma C, Sharma M. A comparative analysis of the baska mask versus
I-gel for general anesthesia in surgical patients undergoing laparoscopic
cholecystectomy. Acta Med Int 2018;5:69-73)
METHODOLOGY:
The study will be conducted after
getting approval from ethics committee of King George’s Medical University,
Lucknow. A computer-generated system will be used for randomization by creating
a list of number each number referred to one of the two groups.
Group A: Patients in which SAD
used is Baska mask
Group B: Patients in which SAD
used is LMA Blockbuster
On arrival in the operating room,
patients will be subjected to the standard monitoring like ECG, noninvasive
blood pressure, heart rate, temperature and SpO2 and a baseline vitals
parameter will be recorded.
They all will be subjected to the
same anaesthetic protocol. Induction will be done in supine position with
fentanyl (2 mcg/kg) and propofol (2 mg/kg) after 3-minute preoxygenation with
100 % O2 followed by muscle relaxant vecoronium (0.1mg/kg), to facilitate
device placement Baska mask, LMA Blockbuster to be used of size 3,4 no. of
either device as their size varies according to weight of the patient.
All SADs will be lubricated on
back surface of cuff before insertion. SAD placement will be done after
achieving adequate relaxation. The time of successful placement of LMA will be
defined as the duration from the time anesthesiologist picks up the LMA till
the capnography tracing is obtained. Effective ventilation will be tested by
observation of chest wall movement and capnography curve on the monitor.
Ventilation will be set at an inspired tidal volume of 6-8 ml/kg and
respiratory rate of 12 minutes, inspiratory expiratory ratio of 1:2 with no
PEEP. If there is no chest wall movement and no capnography tracing on monitor,
that attempt will be considered as failed. We will also note total no of
attempt in each case and no. of successful placement in first attempt. During
the procedure hemodynamic changes will be recorded. The study will be able to
provide better option for laparoscopic cholecystectomy procedures.
After successful placement of
either device oropharyngeal leak pressure will be measured. OLP test will be
performed after the loss of spontaneous respiration. The OLP is defined as the
plateau airway pressure reached with the fresh gas flow at the rate of 6
lit/min and pressure adjustment valve set to 70 cm H20. The peak pressure at
which leaking from airway device will be confirmed by hearing noisy sound or
stethoscope then setting will be back to previous normal.
After completion of surgery
device will be removed and patient will be shifted to postoperative recovery
room. Two hours after surgery patient will be assessed for any airway morbidity
by asking him like sore throat (constant pain), dysphonia(hoarseness) or
dysphagia. Device will also be checked for any blood stain to assess any trauma
during insertion.
We had assessed and recorded OLP just after and 30 min after insertion of
the device. It will be determined by closing the expiratory valve at a fixed
gas flow of 5 L/min and recording the airway pressure at which equilibrium will
be reached. The airway pressure will be not allowed to exceed 40 cm of water.
We also assessed the time taken for insertion of device, i.e., ease of
insertion, i.e., easy insertion – insertion at first attempt with no
resistance; difficult insertion – insertion with resistance or at second
attempt; and failed insertion – insertion not possible even after two attempts.
Manipulations will be done in the form of increasing the depth of insertion;
giving jaw thrust or changing size of the device. For standardization,
intra-abdominal pressure (IAP) will be maintained at 12–16 mmHg. We also
assessed gastric tube insertion time. The PAP, leak fraction, hemodynamic
responses (heart rate and mean arterial blood pressure), SPO2 and
end tidal carbon dioxide (EtCO2)will be also recorded at 1 min after
induction (T1), 5 min before carboperitonium (T2), 5 min after carboperitonium
(T3), 5 min before removal of carboperitonium (T4), and 5 min after removal of
carboperitonium (T5) along with the baseline (T0) value. To maintain target SPO2
(>95%) and EtCO2 (<45 mm Hg) by adjusting the fraction of
inspired oxygen, respiratory rate, and tidal volume. When SPO2 was
94%–90%, the oxygenation will be graded as suboptimal, and the oxygenation will
be graded as failed if SPO2 was <90%. The leak fraction will be calculated
by the formula: tidal volume inspires − tidal volume expired/tidal volume
inspired (Vinsp − Vexp/Vinsp) × 100 to assess the device stability. Incidence
of gastric distension/desaturation/aspiration/cough/any lip, tongue, and dental
injury will be recorded. Postoperative laryngo-pharyngeal morbidity (pain in
throat/change of voice/difficulty in swallowing) will be assessed after 2 h of
removal of the device. The study will be able to provide better option for
laparoscopic cholecystectomy procedures.

Statistical analysis:
All data will
be statistically analyzed using SPSS
statistical software, Version 22nd. The quantitative data (OLP, times for
insertion of SGA and gastric tube) will be analyzed using the one-way analysis
of variance test and Bonferroni post hoc multiple comparison test.
Qualitative data (ease of insertion of SGA and gastric tube, first attempt
insertion success rate, number of insertion attempts, and any complications)
will be compared using Chi-squared or Fisher’s exact test. A P <
0.05 was considered significant.
References:
1. Stauffer JL, Olson DE, Petty TL.
Complications and consequences of endotraqueal intubation and tracheotomy. Am J
Med. 1981;70:65-76.
2. Grillo HC,
Donahue DM, Mathisen DJ. Postintubation tracheal stenosis. J Thorac Cardiovasc
Surg. 1995;109:486-93
3. Ferdinende P, Kim D. Prevention of
postintubation laryngotraqueal stenosis. Acta Otorhinolarymgol Belg.
1995;49:341-6.
4. Kyle M.
Behrens,Richard E. Galgon .Supraglottic airway versus endotracheal tube during
interventional pulmonary procedures – a retrospective study BMC Anesthesiology
volume 19, Article number : 196 (2019)
5. Sharma B,
Sahai C, Sood J. Extraglottic airway devices: technology update [published
correction appears in Med Devices (Auckl). 2018 Jan 04;11:27]. Med Devices
(Auckl). 2017;10:189-205.
6. JJ Gatward, TM Cook, C Seller, J Handel, T
Simpson, V Vanek, F Kelly. Evaluation of the size 4 i-gel in one hundred
non-paralysed patients. Anaesthesia 63 (10), 1124-1130, 2008 |